Neal Bradsher Oncocyte Corp

As of April 15, 2022


What is Neal Bradsher's Net Worth?

The current estimated net worth of Oncocyte Corp's Neal Bradsher is estimated to be about $1.06B . Neal Bradsher owns about 23,356,842 units of Oncocyte Corp common stock. In the last 5 years at Oncocyte Corp, Neal Bradsher has sold an estimated value of $0 worth.

What is Neal Bradsher's Past Insider Trading?

Neal Bradsher's largest purchase order was 6,003,752 units , worth over $8M on April 15, 2022. In total, Neal Bradsher has made about 13 transactions over 5 years of their time at Oncocyte Corp. Neal Bradsher usually trades in February, with the busiest year in 2019.

BROADWOOD PARTNERS LP, NEAL BRADSHER, BROADWOOD CAPITAL INC

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What are Oncocyte Corp's Past Insider Trades?

Oncocyte Corp's most recent insider trade came on June 28, 2022 by Pura Vida Investments Llc and Efrem Kamen who sold 99,386 units worth $102.63K . In the last 4 years, insiders at Oncocyte Corp have sold an estimated value of $16.41M and bought an estimated value of $91.64M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Mitch Levine, Chief Financial Officer,  Broadwood Capital Inc,  and Broadwood Partners Lp .

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1